862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 1. Recreational Drugs and HIV Antiretrovirals. A Guide to Interactions for Clinicians
|
|
|
- Blaze Clark
- 8 years ago
- Views:
Transcription
1 862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 1 Recreational Drugs and HIV Antiretrovirals A Guide to Interactions for Clinicians 2014
2 862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 2 Recreational Drugs and HIV Antiretrovirals A Guide to Interactions for Clinicians Prepared by: Antonio Urbina, MD, John Faragon, PharmD, BCPS, AAHIVP This clinical support tool is sponsored by the New York/New Jersey AIDS Education Training Center (NY/NJ AETC).The NY/NJ AETC is funded by the Health Resources and Services Administration (HRSA) and is part of the National AIDS Education Training Center Program, a network of federally funded regional and national centers that conduct targeted multidisciplinary HIV/AIDS education and training programs for health care providers. The authors would like to acknowledge authors involved with previous versions of this guide, Christine Kubin, PharmD and Audrey Castillo, MPH. Providers are encouraged to also review our guide entitled Opioid Pain Management and Addiction Management Medications: Drug Interactions with HIV Antiretrovirals: A Guide to Interactions for Clinicians that may be found on our website. Disclaimer: Neither the AIDS Education and Training Centers nor HRSA condone or recommend the use of illicit drugs in any context. The data in this guide are intended for use by clinicians and other health care providers to provide advice that may reduce harm to patients who use these substances in conjunction with antiretroviral agents. The data in this guide are a compilation of information obtained from published and anecdotal studies through January * PLEASE REFER TO PAGE 14 OF THIS GUIDE FOR IMPORTANT HARM REDUCTION THAT SHOULD BE SHARED WITH PATIENTS. NY/NJ AIDS Education and Training Center Columbia University College of Physicians and Surgeons Department of Psychiatry 100 Haven Avenue, Suite 3IG NewYork, NY nynjaetc@columbia.edu
3 862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 3 ALCOHOL AMPHETAMINES (Crystal) Confusion, disorientation, incoordination, loss of Paranoia, anxiety, depression, hallucinations, tachycardia, hypertension balance and judgement, respiratory depression, stroke, myocardial infarction, hyperthermia, rhabdomyolysis, diarrhea, stupor, coma erectile dysfunction, teeth grinding PHARMACOKINETICS Metabolized by alcohol dehydrogenase and Metabolized by hydroxylation and deamination via CYP2D6 pathway; CYP2D6 aldehyde dehydrogenase; alcohol may induce inhibitors may increase amphetamine levels (try to avoid) CYP2E1 and CYP3A delavirdine (Rescriptor) delavirdine (Rescriptor) efavirenz (Sustiva) No known interactions specific to efavirenz (Sustiva) No known interactions specific to nevirapine (Viramune) nevirapine (Viramune) etravirine (Intelence) etravirine (Intelence) rilpivirine (Edurant) rilpivirine (Edurant) abacavir (ABC, Ziagen) Increases abacavir AUC ~40% (decreased abacavir (ABC,Ziagen) abacavir metabolism by alcohol dehydrogenase) *Complera (RPV/TDF/FTC) *Complera (RPV/TDF/FTC) didanosine (ddl, Videx) Increased risk of pancreatitis didanosine (ddl, Videx) emtricitabine (FTC, Emtriva) emtricitabine (FTC, Emtriva) *SEE INDIVIDUAL COMPONENTS lamivudine (3TC, Epivir) *SEE INDIVIDUAL COMPONENTS lamivudine (3TC, Epivir) stavudine (d4t, Zerit) stavudine (d4t, Zerit) tenofovir (TDF,Viread) tenofovir (TDF,Viread) zidovudine (AZT, ZDV, Retrovir) zidovudine (AZT, ZDV, Retrovir) Protease Inhibitors Protease Inhibitors Use of full dose ritonavir or low dose fosamprenavir (Lexiva) No known interactions specific to amprenavir (Agenerase) ritonavir for boosting other protease atazanavir (Reyataz). fosamprenavir (Lexiva) inhibitors has the potential to increase darunavir (Prezista) atazanavir (Reyataz) amphetamine levels in the blood. indinavir (Crixivan) darunavir (Prezista) No known interactions specific to lopinavir/ritonavir (Kaletra) indinavir (Crixivan). Refer to comments nelfinavir (Viracept) lopinavir/ritonavir (Kaletra) for this drug class in general. ritonavir (Norvir) nelfinavir (Viracept) saquinavir (Fortovase, Invirase) ritonavir (Norvir) tipranavir (Aptivus) saquinavir (Fortovase, Invirase) tipranavir (Aptivus) Increases amphetamine blood levels 2-3 times Continued next page 3
4 862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 4 ALCOHOL (Cont d) AMPHETAMINES (Crystal) (Cont d) Confusion, disorientation, incoordination, loss of Paranoia, anxiety, depression, hallucinations, tachycardia, hypertension balance and judgement, respiratory depression, stroke, myocardial infarction, hyperthermia, rhabdomyolysis, diarrhea, stupor, coma erectile dysfunction, teeth grinding PHARMACOKINETICS Metabolized by alcohol dehydrogenase and Metabolized by hydroxylation and deamination via CYP2D6 pathway; CYP2D6 aldehyde dehydrogenase; alcohol may induce inhibitors may increase amphetamine levels (try to avoid) CYP2E1 and CYP3A Maraviroc (Selzentry) No known interactions specific to Maraviroc (Selzentry) No known interactions specific to Elvitegravir/cobicistat/ No known interactions specific to Elvitegravir/cobicistat/ Potential to increase amphetamine levels in the blood Dolutegravir (Tivicay) Dolutegravir (Tivicay) No known interactions specific to Raltegravir (Isentress) Raltegravir (Isentress) PHARMACOKINETICS AMYL NITRITE (amyl nitrate, poppers) Reduces glutathioine levels; inhaling the fumes acts as a vasodilator (hypotension, tachycardia, headaches), skin flushing BENZODIAZEPINES CNS depression, drowsiness, memory loss, impaired coordination Most agents extensively metabolized in the liver by the CYP3A4 system; lorazepam, oxazepam, and temazepam metabolized by onjugation via glucuronidation. delavirdine (Rescriptor) delavirdine (Rescriptor) efavirenz (Sustiva) No known interactions specific to efavirenz (Sustiva) nevirapine (Viramune) nevirapine (Viramune) etravirine (Intelence) etravirine (Intelence) rilpivirine (Edurant) rilpivirine (Edurant) Likely inhibits benzodiazepine metabolism through CYP3A4 inhibitionand increases risk of adverse effects; concomitant use should be avoided Diazepam drug levels may be increased by etravirine; a decrease in diazepam dosage may be needed Continued next page 4
5 862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 5 AMYL NITRITE (amyl nitrate, poppers) (Cont d) Reduces glutathioine levels; inhaling the fumes acts as a vasodilator (hypotension, tachycardia, headaches), skin flushing PHARMACOKINETICS BENZODIAZEPINES (Cont d) CNS depression, drowsiness, memory loss, impaired coordination Most agents extensively metabolized in the liver by the CYP3A4 system; lorazepam, oxazepam, and temazepam metabolized by conjugation via glucuronidation. abacavir (ABC, Ziagen) abacavir (ABC, Ziagen) No known interactions specific to. *Complera (RPV/TDF/FTC) *Complera (RPV/TDF/FTC) didanosine (ddl, Videx) didanosine (ddl, Videx) emtricitabine (FTC, Emtriva) emtricitabine (FTC, Emtriva) SEE INDIVIDUAL COMPONENTS lamivudine (3TC, Epivir) lamivudine (3TC, Epivir) stavudine (d4t, Zerit) stavudine (d4t, Zerit) tenofovir (TDF,Viread) tenofovir (TDF,Viread) zidovudine (AZT, ZDV, Retrovir) zidovudine (AZT, ZDV, Retrovir) Protease Inhibitors No known interactions specific to Protease Inhibitors amprenavir (Agenerase) amprenavir (Agenerase) fosamprenavir (Lexiva) fosamprenavir (Lexiva) atazanavir (Reyataz) atazanavir (Reyata darunavir (Prezista) darunavir (Prezista) indinavir (Crixivan) indinavir (Crixivan) lopinavir/ritonavir (Kaletra) lopinavir/ritonavir (Kaletra) nelfinavir (Viracept) nelfinavir (Viracept) ritonavir (Norvir) ritonavir (Norvir) saquinavir (Fortovase, Invirase) saquinavir (Fortovase, Invirase) tipranavir (Aptivus) tipranavir (Aptivus) Maraviroc (Selzentry) No known interactions specific to Maraviroc (Selzentry) Elvitegravir/cobicistat/ No known interactions specific to Elvitegravir/cobicistat/ Dolutegravir (Tivicay) Dolutegravir (Ticivay) Raltegravir (Isentress) Raltegravir (Isentress) No known interactions specific to *SEE INDIVIDUAL COMPONENTS Use of PIs with benzodiazepines should be avoided due to increased risk of sedation and respiratory depression; midazolam and triazolam specifically contraindicated with all PIs. IV midazolam can be used with caution as a single dose if monitored. No known interactions specific to. Refer to comments for this drug class in general. Decreases therapeutic effect of lorazepam, oxazepam, and temazepam (monitor for withdrawal) No known interactions specific to May increase AUC of intravenous benzodiazepines; especially midazolam and diazepam. Avoid with oral midazolam and triazolam. IV midazolam can be used with caution as a single dose if monitored. No known interactions specific to 5
6 862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 6 COCAINE (coke, blow) ECSTASY (X, MDMA) Increases rate of HIV viral replication in vitro, hypertension, cardiac Tachycardia, hypertension, hyperthermia, dehydration, dry mouth, dysrhythmias, myocardial infarction, seizures, depression, anxiety tense jaw, teeth grinding, depression PHARMACOKINETICS Mainly metabolized by nonspecific tissue and CYP2D6 demethylation important in metabolism; 2D6 inhibitors are plasma esterases; some cocaine likely to increase ecstasy levels metabolism (-10%) via CYP3A4 delavirdine (Rescriptor) delavirdine (Rescriptor) efavirenz (Sustiva) efavirenz (Sustiva) nevirapine (Viramune) No known interactions specific to nevirapine (Viramune) No known interactions specific to etravirine (Intelence) etravirine (Intelence) rilpivirine (Edurant) rilpivirine (Edurant) abacavir (ABC, Ziagen) abacavir (ABC,Ziagen) *Complera (RPV/TDF/FTC) *Complera (RPV/TDF/FTC) didanosine (ddl, Videx) *SEE INDIVIDUAL COMPONENTS didanosine (ddl, Videx) *SEE INDIVIDUAL COMPONENTS emtricitabine (FTC, Emtriva) emtricitabine (FTC, Emtriva) lamivudine (3TC, Epivir) lamivudine (3TC, Epivir) ) stavudine (d4t, Zerit) stavudine (d4t, Zerit) tenofovir (TDF,Viread) tenofovir (TDF,Viread) zidovudine (AZT, ZDV, Retrovir) zidovudine (AZT, ZDV, Retrovir) Protease Inhibitors No known interactions specific to Protease Inhibitors Increase levels of ecstasy amprenavir (Agenerase) amprenavir (Agenerase) No known interactions specific to this fosamprenavir (Lexiva) fosamprenavir (Lexiva) combination. Refer to comments for atazanavir (Reyataz) atazanavir (Reyataz)) this drug class in general darunavir (Prezista) darunavir (Prezista)) Increases risk of kidney stones indinavir (Crixivan) indinavir (Crixivan) due to dehydration lopinavir/ritonavir (Kaletra) lopinavir/ritonavir (Kaletra) Potential to increase ecstasy levels nelfinavir (Viracept) nelfinavir (Viracept) Increases ecstasy levels 5-10 times ritonavir (Norvir) ritonavir (Norvir) (AVOID) saquinavir (Fortovase, Invirase) saquinavir (Fortovase, Invirase) tipranavir (Aptivus) tipranavir (Aptivus) 6 Continued next page
7 862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 7 COCAINE (coke, blow) (Cont d) ECSTASY (X, MDMA) (Cont d) Increases rate of HIV viral replication in vitro, hypertension, cardiac Tachycardia, hypertension, hyperthermia, dehydration, dry mouth, dysrhythmias, myocardial infarction, seizures, depression, anxiety tense jaw, teeth grinding, depression PHARMACOKINETICS Mainly metabolized by nonspecific tissue and CYP2D6 demethylation important in metabolism; 2D6 inhibitors are plasma esterases; some cocaine likely to increase ecstasy levels metabolism (-10%) via CYP3A4 Maraviroc (Selzentry) No known interactions specific to Maraviroc (Selzentry) No known interactions specific to Elvitegravir/cobicistat/ Elvitegravir/cobicistat/ Potential to increase ecstasy levels Dolutegravir (Tivicay) No known interactions specific to Dolutegravir (Tivicay) No known interactions specific to Raltegravir (Isentress) Raltegravir (Isentress) Erectile Dysfunction Agents (avanafil (Stendra), sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra)) Hypotension, tachycardia, arrhythmias (cardiac arrest and death), headache, flushing, rhinitis, dyspepsia, nausea, and visual effects (e.g. light sensitivity, changes in color vision), priapism PHARMACOKINETICS Metabolized in the liver via CYP3A4 delavirdine (Rescriptor) efavirenz (Sustiva) nevirapine (Viramune) etravirine (Intelence) rilpivirine (Edurant) Potential to significantly increase avanafil, sildenafil, tadalafil, vardenafil concentrations. Use sildenafil at reduced doses of 25 mg every 48 hours, tadalafil at reduced doses of 10 mg every 72 hours, vardenafil at reduced doses of no more than 2.5 mg every 72 hours and monitor closely for adverse effects. Do not use with avanafil. No known interactions specific to. Etravirine has been shown to decrease sildenafil concentrations, though may be used together without sildenafil dosage adjustment. Sildenafil dosage may need to be adjusted based upon clinical effect. Similar interactions are also predicted with tadalafil and vardenafil. Continued next page 7
8 862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 8 Erectile Dysfunction Agents (Cont d) (avanafil (Stendra), sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra)) Hypotension, tachycardia, arrhythmias (cardiac arrest and death), headache, flushing, rhinitis, dyspepsia, nausea, and visual effects (e.g. light sensitivity, changes in color vision), priapism PHARMACOKINETICS Metabolized in the liver via CYP3A4 abacavir (ABC, Ziagen) *Complera (RPV/TDF/FTC) didanosine (ddl, Videx) emtricitabine (FTC, Emtriva) lamivudine (3TC, Epivir) stavudine (d4t, Zerit) tenofovir (TDF,Viread) zidovudine (AZT, ZDV, Retrovir) No known interactions specific to *SEE INDIVIDUAL COMPONENTS Protease Inhibitors amprenavir (Agenerase) fosamprenavir (Lexiva) atazanavir (Reyataz) darunavir (Prezista) indinavir (Crixivan) lopinavir/ritonavir (Kaletra) nelfinavir (Viracept) ritonavir (Norvir) saquinavir (Fortovase, Invirase) tipranavir (Aptivus) Maraviroc (Selzentry) No known interactions specific to Elvitegravir/cobicistat/ Dolutegravir (Tivicay) Raltegravir (Isentress) Potential to significantly increase avanafil, sildenafil, tadalafil, vardenafil concentrations. Use sildenafil at reduced doses of 25 mg every 48 hours, tadalafil at reduced doses of 10 mg every 72 hours, vardenafil at reduced doses of no more than 2.5 mg every 72 hours and monitor closely for adverse effects. Do not use with avanafil. No known interactions specific to. Refer to comments for this drug class in general Increases sildenafil AUC ~340% and vardenafil AUC 16-fold. May increase tadalafil concentrations. Refer to comments for this drug class in general. Monitor closely for adverse effects. Increases sildenafil AUC 1000%, tadalafil AUC 124%, and vardenafil AUC 49-fold and half-life 5-6 fold. Refer to comments for this drug class in general. Monitor closely for adverse effects. Increases sildenafil AUC ~210%. May increase tadalafil and vardenafil concentrations. Refer to comments for this drug class in general. Monitor closely for adverse effects. Potential to significantly increase avanafil, sildenafil, tadalafil, vardenafil concentrations. Use sildenafil at reduced doses of 25 mg every 48 hours, tadalafil at reduced doses of 10 mg every 72 hours, vardenafil at reduced doses of no more than 2.5 mg every 72 hours and monitor closely for adverse effects. Do not use with avanafil. No known interactions specific to 8
9 862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 9 GHB HEROIN (smack, brown junk, China White) (gamma-hydroxy-butyrate, grievous bodily harm, liquid X) Dreamlike state of warmth and well-being with small doses; CNS Seizures, bradycardia, severe respiratory depression, drowsiness, respiratory depression, constricted pupils, depression, hypotension, vomiting coma, death nausea/vomiting with excessive doses PHARMACOKINETICS Utilizes CYP2D6 pathway for metabolism Utilizes CYP3A4 pathway for metabolism delavirdine (Rescriptor) delavirdine (Rescriptor) efavirenz (Sustiva) No known interactions specific to efavirenz (Sustiva) No known interactions specific to nevirapine (Viramune) nevirapine (Viramune) etravirine (Intelence) etravirine (Intelence) rilpivirine (Edurant) rilpivirine (Edurant) abacavir (ABC, Ziagen) abacavir (ABC, Ziagen) *Complera (RPV/TDF/FTC) *SEE INDIVIDUAL COMPONENTS *Complera (RPV/TDF/FTC) *SEE INDIVIDUAL COMPONENTS didanosine (ddl, Videx) didanosine (ddl, Videx) emtricitabine (FTC, Emtriva) emtricitabine (FTC, Emtriva) lamivudine (3TC, Epivir) lamivudine (3TC, Epivir) stavudine (d4t, Zerit) stavudine (d4t, Zerit) tenofovir (TDF,Viread) tenofovir (TDF,Viread) zidovudine (AZT, ZDV, Retrovir) zidovudine (AZT, ZDV, Retrovir) Protease Inhibitors Protease Inhibitors amprenavir (Agenerase) PIs potentially increase drug levels of GHB amprenavir (Agenerase) Possible decrease in heroin levels fosamprenavir (Lexiva) fosamprenavir (Lexiva) atazanavir (Reyataz) atazanavir (Reyataz) No known interactions specific to darunavir (Prezista) No known interactions specific to darunavir (Prezista). indinavir (Crixivan). Refer to comments for indinavir (Crixivan) Refer to comments for this drug class lopinavir/ritonavir (Kaletra) this drug class in general lopinavir/ritonavir (Kaletra) in general. nelfinavir (Viracept) nelfinavir (Viracept) ritonavir (Norvir) ritonavir (Norvir) Reduces heroin levels by 50% saquinavir (Fortovase, Invirase) saquinavir (Fortovase, Invirase) tipranavir (Aptivus) tipranavir (Aptivus) Continued next page 9
10 862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 10 GHB (Cont d) HEROIN (smack, brown junk, China White) (Cont d) (gamma-hydroxy-butyrate, grievous bodily harm, liquid X) Dreamlike state of warmth and well-being with small doses; CNS Seizures, bradycardia, severe respiratory depression, drowsiness, respiratory depression, constricted pupils, depression, hypotension, vomiting coma, death nausea/vomiting with excessive doses PHARMACOKINETICS Utilizes CYP2D6 pathway for metabolism Utilizes CYP3A4 pathway for metabolism Maraviroc (Selzentry) No known interactions specific to Maraviroc (Selzentry) Elvitegravir/cobicistat/ Potential increase in GHB levels Elvitegravir/cobicistat/ with cobicistat Dolutegravir (Tivicay) No known interactions specific to Dolutegravir (Tivicay) Raltegravir (Isentress) Raltegravir (Isentress) No known interactions specific to No known interactions specific to KETAMINE (K, Special K) Paranoia, anxiety, mania, hallucinations, "K-hole" (semi-catatonic stupor). Elevated levels may cause tachycardia, hypertension, respiratory depression PHARMACOKINETICS Undergoes N-demethylation and hydroxylation (possibly mediated by CYP3A4); possible weak inhibitor of CPY2D1 and CYP3A4 LSD (acid) Paranoia, visual and auditory hallucinations delavirdine (Rescriptor) delavirdine (Rescriptor) efavirenz (Sustiva) nevirapine (Viramune) No known interactions specific to efavirenz (Sustiva) nevirapine (Viramune) No known interactions specific to etravirine (Intelence) etravirine (Intelence) rilpivirine (Edurant) rilpivirine (Edurant) Continued next page 10
11 862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 11 KETAMINE (K, Special K) (Cont d) LSD (acid) (Cont d) Paranoia, anxiety, mania, hallucinations, "K-hole" (semi-catatonic stupor). Paranoia, visual and auditory hallucinations Elevated levels may cause tachycardia, hypertension, respiratory depression PHARMACOKINETICS Undergoes N-demethylation and hydroxylation (possibly mediated by CYP3A4); possible weak inhibitor of CPY2D1 and CYP3A4 abacavir (ABC, Ziagen) No known interactions specific to abacavir (ABC,Ziagen) No known interactions specific to *Complera (RPV/TDF/FTC) *SEE INDIVIDUAL COMPONENTS *Complera (RPV/TDF/FTC) *SEE INDIVIDUAL COMPONENTS didanosine (ddl, Videx) didanosine (ddl, Videx) emtricitabine (FTC, Emtriva) emtricitabine (FTC, Emtriva) lamivudine (3TC, Epivir) lamivudine (3TC, Epivir) stavudine (d4t, Zerit) stavudine (d4t, Zerit) tenofovir (TDF,Viread) tenofovir (TDF,Viread) zidovudine (AZT, ZDV, Retrovir) zidovudine (AZT, ZDV, Retrovir) Protease Inhibitors Likely increase the effect of ketamine Protease Inhibitors No known interactions specific to amprenavir (Agenerase (more sedation, increased heart rate and blood amprenavir (Agenerase) fosamprenavir (Lexiva) pressure). Effects last longer fosamprenavir (Lexiva) atazanavir (Reyataz) No known interactions specific to atazanavir (Reyataz) darunavir (Prezista). Refer to comments for darunavir (Prezista) indinavir (Crixivan) this drug class in general indinavir (Crixivan) lopinavir/ritonavir (Kaletra) lopinavir/ritonavir (Kaletra) nelfinavir (Viracept) nelfinavir (Viracept) ritonavir (Norvir) Combination may increase risk of ritonavir (Norvir) saquinavir (Fortovase, Invirase) drug induced hepatitis saquinavir (Fortovase, Invirase) tipranavir (Aptivus) tipranavir (Aptivus) Maraviroc (Selzentry) No known interactions specific to Maraviroc (Selzentry) No known interactions specific to Elvitegravir/cobicistat/ Potential increase in ketamine levels; Elvitegravir/cobicistat/ effects may last longer with cobicistat No known interactions specific to Dolutegravir (Tivicay) No known interactions specific to Dolutegravir (Tivicay) Raltegravir (Isentress) Raltegravir (Isentress) 11
12 862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 12 MARIJUANA (Tetrahydrocannabinol; THC) Tachycardia, loss of inhibitions, dry mouth, visual hallucinations METHADONE Generalized CNS depression PHARMACOKINETICS Metabolized in the liver to active metabolite Primarily utilizes CYP3A4 pathway for metabolism; inhibitor of CYP2D66 (11-hydroxy THC) via CYP3A4, 2C9, and 2C6; and CYP3A4 inhibitors/inducers of CYP3A4 may interfere with THC metabolism delavirdine (Rescriptor) delavirdine (Rescriptor) efavirenz (Sustiva) efavirenz (Sustiva) nevirapine (Viramune) nevirapine (Viramune) etravirine (Intelence) etravirine (Intelence) rilpivirine (Edurant) rilpivirine (Edurant) No known interactions specific to abacavir (ABC,Ziagen) abacavir (ABC,Ziagen) *SEE INDIVIDUAL COMPONENTS Complera (RPV/TDF/FTC Complera (RPV/TDF/FTC didanosine (ddl, Videx) didanosine (ddl, Videx) emtricitabine (FTC, Emtriva) emtricitabine (FTC, Emtriva) lamivudine (3TC, Epivir) lamivudine (3TC, Epivir) stavudine (d4t, Zerit) stavudine (d4t, Zerit) tenofovir (TDF,Viread) tenofovir (TDF,Viread) zidovudine (AZT, ZDV, Retrovir) zidovudine (AZT, ZDV, Retrovir) Protease Inhibitors Potential to increase THC levels Protease Inhibitors amprenavir (Agenerase) No known interactions specific to amprenavir (Agenerase) fosamprenavir (Lexiva). Refer to comments for this fosamprenavir (Lexiva) atazanavir (Reyataz) drug class in general atazanavir (Reyataz) darunavir (Prezista) In one study, concentrations of atazanavir darunavir (Prezista) indinavir (Crixivan) were reduced up to 60% in patients using indinavir (Crixivan) lopinavir/ritonavir (Kaletra) marijuana. Study did not differentiate lopinavir/ritonavir (Kaletra) nelfinavir (Viracept) whether atazanavir was boosted with nelfinavir (Viracept) ritonavir (Norvir) ritonavir or not. ritonavir (Norvir) saquinavir (Fortovase, Invirase) saquinavir (Fortovase, Invirase) tipranavir (Aptivus) tipranavir (Aptivus) No known interactions specific to Decreases methadone AUC significantly (~60%); titrate methadone dose to effect Decreases methadone AUC significantly (~40-50%); titrate methadone dose to effect Increases methadone clearance ~22% (an increase in methadone dose may be required in some patients Decreases didanosine AUC ~41-60% (consider didanosine tablet form dose increase or switch to enteric-coated formulation which may not be affected to the same degree ) Decreases stavudine AUC~23% Increases zidovudine AUC ~40% (increases AUC ~29% during chronic treatment) Interaction highly variable and patients should be evaluated on an individual basis Decreases methadone levels ~13-30%; monitor for withdrawal and consider methadone dose increase if needed Decreases methadone AUC ~16-36% (may require methadone dose increase) Decreases methadone AUC ~26-53% (may require methadone dose increase) Decreases methadone AUC ~47% (may require methadone dose increase) Decreases methadone AUC ~37% (may require methadone dose increase) Decrease methadone AUC by ~50% (may require methadone dosage increase) 12
13 862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 13 MARIJUANA (Tetrahydrocannabinol; THC) (Cont d) METHADONE (Cont d) Tachycardia, loss of inhibitions, dry mouth, Generalized CNS depression visual hallucinations PHARMACOKINETICS Metabolized in the liver to active metabolite Primarily utilizes CYP3A4 pathway for metabolism; inhibitor of CYP2D66 (11-hydroxy THC) via CYP3A4, 2C9, and 2C6; and CYP3A4 inhibitors/inducers of CYP3A4 may interfere with THC metabolism Maraviroc (Selzentry) No known interactions specific to Maraviroc (Selzentry) No known interactions specific to Elvitegravir/cobicistat/ Potential to increase THC level Elvitegravir/cobicistat/ No known interactions specific to Dolutegravir (Tivicay) No known interactions specific to Dolutegravir (Tivicay) Raltegravir (Isentress) Raltegravir (Isentress) 13
14 862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 14 PATIENT INFORMATION TO REDUCE HARM ALCOHOL If you take ddi, do not drink alcohol. Try to avoid alcohol or use modestly. AMYL NITRITE (amyl nitrate, poppers) Do not use with avanafil (Stendra), sildenafil (Viagra), vardenafil (Levitra) or adalafil (Cialis). Heart problems, glaucoma, or anemia makepoppers more dangerous. COCAINE (coke, blow) Don t get so high you forget to stick to your antiretroviral regimen. Avoid cocaine if you have heart or liver problems, or high blood pressure Erectile Dysfunction Agents Do not mix with amyl or butyl nitrates (poppers). Combination can cause sudden drop in blood pressure leading to fainting or heart attack. GHB Start with half-teaspoon, wait half-hour before taking more. Do not mix with alcohol, tranquilizers, pain-killers, or allergy medications. Do not use if you are alone. The dose you used last week can kill you this week. KETAMINE (K, Special K) Start with 1/3 or 1/2 of usual dose. Wait a half-hour before doing more. Always use with a friend, never alone. AMPHETAMINES (Crystal) Avoid use if you have heart or liver problems, or high blood pressure. Recent reports of transmitted HIV resistance in patients using methamphetamine and practicing unsafe sex. BENZODIAZEPINES Avoid with midazolam and triazolam. Caution with other medications in this class. Discuss with provider to ensure potential interactions are identified. ECSTASY (X, MDMA) Start with 1/4 or 1/2 tablet. Drink plenty of water. HEROIN (smack, brown junk, China, White) Start with normal dose and increase only if you experience less of a hit and less buzz. Safe injecting. Do not mix with other recreational drugs. METHADONE Any changes to your methadone regimen or HIV medications should be reported to both providers to ensure potential interactions are identified. 14
15 862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 15 RESOURCES The National AETC Program also includes the following services: National HIV/AIDS Clinicians Consultation Center: Offering treating clinicians current HIV clinical and drug information and individualized, expert case consultation. Post-Exposure Prophylaxis 24 hour hotline: HIV-4911 Providing consulation for occupational exposures. Perinatal Hotline: Providing consulation for perinatal exposure and treatment. AETC HIV/AIDS National Resource Center: Providing resources (including curricula and lecture slide sets) on HIV disease treatment, education and data. 15
16 862060_Rec Drug Guide.qxd 2/5/14 1:06 PM Page 16 FOR FURTHER INFORMATION, PLEASE VISIT ONE OF THE FOLLOWING WEBSITES: NY/NJ AIDS Education and Training Center U.S. DHHS AIDS Info aidsinfo.nih.gov NYSDOH AIDS Institute Clinical Resources Substance Abuse and Mental Health Services Administration Addiction Technology Transfer Center Harm Reduction Coalition 16
HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet 02300699 1 tablet daily. Complera 200/25/300 mg tablet 02374129 1 tablet daily
HIV MEDICATIONS AT A GLANCE Generic Name Trade Name Strength DIN Usual Dosage Single Tablet Regimen (STR) Products Efavirenz/ emtricitabine/ Emtricitabine/ rilpivirine/ elvitegravir/ cobicistat/ emtricitabine/
HIV 1. A reference guide for prescription HIV-1 medications
HIV 1 A reference guide for prescription HIV-1 medications Several different kinds of antiretroviral drugs are currently used to treat HIV-1 infection. These medicines are the ones most commonly used in
Opioid Pain and Addiction Management Medications Drug. Interactions with HIV Antiretrovirals. A Drug Interaction Guide for Clinicians.
857106_Pain Bro.qxd 6/11/13 7:49 AM Page 1 Opioid Pain and Addiction Management Medications Drug Interactions with HIV Antiretrovirals A Drug Interaction Guide for Clinicians Spring 2013 NY/NJ AIDS Education
Helpful HIV Medication Tables for Pharmacists
861837_Pharmguide.qxd 2/5/14 12:55 PM Page 1 Helpful HIV Medication Tables for Pharmacists New York/New Jersey AIDS Education & Training Center (AETC) www.nynjaetc.org Winter 2014 861837_Pharmguide.qxd
Covered California s 2016 Formularies
Covered California s 2016 Formularies An analysis of the drugs per tier in all 12 health plans that are available for treating and preventing HIV (pp 1 24) and for treating hepatitis B (pp 26 37) and hepatitis
Comprehensive Case Management Reassessment
Comprehensive Case Management Reassessment Reassessment Date: Date of previous Assessment/Reassessment: Name: Client ID # Address: If Reassessment early or late explain: Current HIV Status: Asymptomatic
Drug Treatment Program Update
Drug Treatment Program Update As of May 211 Drug Treatment Program Update A key component of the Centre s mandate is to monitor the impact of HIV/AIDS on British Columbia. The Centre provides essential
Systematic literature search: PICO questions
BHIVA Treatment Guidelines 2014: Systematic literature search questions Page 1 of 5 Systematic literature search: PICO questions 2.1 Questions and PICO criteria Databases: Medline, Embase, Cochrane Library,
Antiretroviral Patient Medication Information Sheets Table of Contents
Antiretroviral Patient Medication Information Sheets Table of Contents 1. About this Resource, Disclaimer, Instructions for Use 2. General information sheet - Provide this to all patients 3. Drug Specific
GENERAL INSTRUCTIONS FOR COMPLETING THE HIV TEST FORM
GENERA INSTRUCTIONS FOR COMPETING THE This form is designed to be read by an Optical Character Recognition (OCR) scanner. The legibility of this form depends on the quality of the a hand written and selected
Marketplace Health Plans Template Assessment Tool October 2014
Marketplace Health Plans Template Assessment Tool October 2014 Beginning in January 2015, state and federal Marketplaces (aka exchanges) will again offer a range of insurance plans called qualified health
North Carolina Marketplace Plans with More Affordable Drug Cost Sharing for People with HIV
North Carolina Marketplace Plans with More Affordable Drug Cost Sharing for People with HIV Of North Carolina s marketplace insurance offerings, only Blue Cross Blue Shield s plans are potentially affordable
Chemotherapy regimen: Dose adjusted EPOCH
Chemotherapy regimen: Dose adjusted EPOCH Agents involved Etoposide 50 mg/m 2 /d continuous IV infusion D 1 4 Doxorubicin 10 mg/m 2 /d continuous IV infusion D 1 4 Vincristine 0.4 mg/m 2 /d IV continuous
Patient Information Leaflet Drug interaction with ED drug treatments
Patient Information Leaflet Drug interaction with ED drug treatments This document is intended for information purposes only and should be used in conjunction with the advice and further details to be
B.C. HIV/AIDS Drug Treatment Program
B.C. HIV/AIDS Drug Treatment Program Monthly Report January 215 215 BC Centre for Excellence in HIV/AIDS DISCLAIMER: This document is published by the British Columbia Centre for Excellence in HIV/AIDS
Treatment Information Service 1 800 HIV 0440 HIV/AIDS. HIV and Its Treatment What You Should Know. 2nd edition
HIV/AIDS Treatment Information Service 1 800 HIV 0440 HIV and Its Treatment What You Should Know 2nd edition HIV/AIDS TREATMENT INFORMATION SERVICE 2nd Edition HIV and Its Treatment: What You Should Know
Contents What are side effects? Why do I need to know about side effects of HIV medications?
Contents What are side effects?................................ 1 Why do I need to know about side effects of HIV medications?.................................. 2 What should I ask my doctor when he or
HIV and the Central Nervous System: neurocognitive aspects VIH y Sistema Nervioso Central: aspectos neurocognitivos
HIV and the Central Nervous System: neurocognitive aspects VIH y Sistema Nervioso Central: aspectos neurocognitivos Gabriele Arendt Department of Neurology, University Hospital of Duesseldorf (UKD) 40
ACA Insurance Enrollment for People living with HIV in North Carolina
ACA Insurance Enrollment for People living with HIV in North Carolina A Guide for the HIV Community In 2015, people living with HIV should take a fresh look at the insurance marketplace. Coverage will
July 3, 2015. III. VA policy:
Antiretroviral Postexposure Prophylaxis After Sexual, Injection- Drug Use, or Other Nonoccupational Exposure to HIV (nonoccupational post- exposure prophylaxis [npep]) VA Greater Los Angeles Healthcare
CO-PAY PROGRAMS FOR HIV and Hepatitis
CO-PAY PROGRAMS FOR HIV and Hepatitis CO-PAY PROGRAMS FOR HIV These programs offer assistance to people with private health insurance for the co-payments they have to make at the pharmacy for their HIV
The Antiretroviral. Pregnancy Registry. Interim Report VOL. 28, NO. 1 1 JANUARY 1989 THROUGH 31 JANUARY 2016. Interim Report. (Issued: June 2016)
The Antiretroviral The Antiretroviral Pregnancy Registry Pregnancy Registry Interim Report VOL. 28, NO. 1 1 JANUARY 1989 THROUGH 31 JANUARY 2016 Interim Report (Issued: June 2016) VOL. (Expiration: 28,
STATE HEALTH REFORM IMPACT MODELING PROJECT. Alabama
STATE HEALTH REFORM IMPACT MODELING PROJECT Alabama January 2013 Prepared by the Center for Health Law and Policy Innovation of Harvard Law School and the Treatment Access Expansion Project BACKGROUND
Presented by: Canadian Working Group on HIV and Rehabilitation
Rehabilitation in the Context of HIV: An Interprofessional Course for Occupational Therapists, Physiotherapists, Speech-Language Pathologists and Audiologists Presented by: Canadian Working Group on HIV
Direct antiviral therapy of hcv and relevant drug drug interactions for ivdu
Direct antiviral therapy of hcv and relevant interactions for ivdu Stefan Mauss Center for HIV and Hepatogastroenterology Duesseldorf, Germany Disclosures Advisory board: Abbvie, BMS, Boehringer Ingelheim,
HIV ONCOLOGY HANDBOOK. Antiretroviral Interactions with Chemotherapy Regimens. Alison Wong, B.pharm., M.Sc. Alice Tseng, Pharm.D.
2014 HIV ONCOLOGY HANDBOOK Antiretroviral Interactions with Chemotherapy Regimens Alison Wong, B.pharm., M.Sc. Chronic Viral Illness Service McGill University Health Centre Montreal, QC Alice Tseng, Pharm.D.,
State Health Reform Impact Modeling Project Florida
State Health Reform Impact Modeling Project Florida January 2013 Prepared by the Center for Health Law and Policy Innovation of Harvard Law School and the Treatment Access Expansion Project Questions may
HIV/AIDS 2014 REPORT MEDICINES IN DEVELOPMENT. Contents. Medicines and Vaccines in Development for HIV Infection
MEDICINES IN DEVELOPMENT HIV/AIDS PRESENTED BY AMERICA S BIOPHARMACEUTICAL RESEARCH COMPANIES 2014 REPORT Biopharmaceutical Company Researchers Are Developing More Than 40 Medicines and Vaccines For HIV
Drug and Alcohol Abuse Prevention Program
Drug and Alcohol Abuse Prevention Program D. A. Dorsey Educational Center is committed to providing a safe and healthy learning environment for all our faculty, staff, and students. Our institution recognizes
How To Deal With Drugs At Kmendree University
McKendree University Drug and Alcohol Policy Standards of Conduct In order for McKendree University to be in compliance with Drug-Free Schools and Communities Act and Education Department General Administrative
New Jersey. State Health Reform Impact Modeling Project
State Health Reform Impact Modeling Project New Jersey January 2013 Prepared by the Center for Health Law and Policy Innovation of Harvard Law School and the Treatment Access Expansion Project Background
South CarolinaJanuary 2013
STATE HEALTH REFORM IMPACT MODELING PROJECT South CarolinaJanuary 2013 Prepared by the Center for Health Law and Policy Innovation of Harvard Law School and the Treatment Access Expansion Project BACKGROUND
State Health Reform Impact Modeling Project Tennessee
State Health Reform Impact Modeling Project Tennessee January 2013 Prepared by the Center for Health Law and Policy Innovation of Harvard Law School and the Treatment Access Expansion Project Background
Antiretroviral Treatment Options for Patients on Directly Acting Antivirals for Hepatitis C. Daclatasvir (Daklinza, DCV, BMS-790052)
Antiretroviral Treatment Options for Patients on Directly Acting Antivirals for Hepatitis C PIs: atazanavir PIs: other Simeprevir with ritonavir- or cobicistat boosted PIs (significant simeprevir AUC).
London Therapeutic Tender Implementation: Guidance for Clinical Use. 4 th June 2014 FINAL
London Therapeutic Tender Implementation: Guidance for Clinical Use 4 th June 2014 FINAL Contents 3. General principles 4. Financial impact of therapeutic tendering for branded ARVs 5. London ARV algorithm:
Maryland. State Health Reform Impact Modeling Project
State Health Reform Impact Modeling Project Maryland January 2013 Prepared by the Center for Health Law and Policy Innovation of Harvard Law School and the Treatment Access Expansion Project Background
District of Columbia
STATE HEALTH REFORM IMPACT MODELING PROJECT District of Columbia January 2013 Prepared by the Center for Health Law and Policy Innovation of Harvard Law School and the Treatment Access Expansion Project
Drug addiction. These factors increase the likelihood of your having an addiction to a legal or an illegal drug:
Drug addiction You may be hooked emotionally and psychologically. You may have a physical dependence, too. If you're addicted to a drug whether it's legal or illegal you have intense cravings for it. You
STATE HEALTH REFORM IMPACT MODELING PROJECT. Georgia
STATE HEALTH REFORM IMPACT MODELING PROJECT Georgia January 2013 Prepared by the Center for Health Law and Policy Innovation of Harvard Law School and the Treatment Access Expansion Project BACKGROUND
CDC occupation Codes used to code ( map ) facility locations
CDC occupation Codes used to code ( map ) facility locations CDC (occupation) Code BLS SOC (2000)* CDC (occupation) Code BLS SOC (2000)* ATT-Attendant/orderly 31-1012 CLA-Clerical/administrative CNA-Nurse
POST-EXPOSURE PROPHYLAXIS IN THE HEALTH CARE SETTING
MARCH 2014 A Quick Guide to POST-EXPOSURE PROPHYLAXIS IN THE HEALTH CARE SETTING HIV PROVIDER REFERENCE SERIES A PUBLICATION OF THE MOUNTAIN PLAINS AIDS EDUCATION AND TRAINING CENTER MountainPlains AIDS
HIV Update: Epidemiology and Pathophysiology
HIV Update: Epidemiology and Pathophysiology MATEC Michigan AIDS Research and Education Center Wayne State University School of Medicine (313) 962-2000 matecmichigan.org 1 Epidemiology of the Epidemic:
1/26/2015. Epidemiology of the Epidemic: World. Epidemiology of the Epidemic: United States. HIV Update: Epidemiology and Pathophysiology
HIV Update: Epidemiology and Pathophysiology MATEC Michigan AIDS Research and Education Center Wayne State University School of Medicine (313) 962-2000 matecmichigan.org Epidemiology of the Epidemic: World
STATE HEALTH REFORM IMPACT MODELING PROJECT. North Carolina
STATE HEALTH REFORM IMPACT MODELING PROJECT North Carolina December 2012 Prepared by the Center for Health Law and Policy Innovation of Harvard Law School and the Treatment Access Expansion Project Questions
DRUG USE. 1300 136 588 ndss.com.au AND TYPE 1 DIABETES
DRUG USE AND TYPE 1 DIABETES 1300 136 588 ndss.com.au The National Diabetes Services Scheme (NDSS) is an initiative of the Australian Government administered by Diabetes Australia. Contents Topic Page
Effects of Illicit Drugs on the Heart and Brain Presented by: Jeffrey Sather, MD, FACEP Trinity Health
2014 Stroke/Cardiac System of Care Conference Effects of Illicit Drugs on the Heart and Brain Presented by: Jeffrey Sather, MD, FACEP Trinity Health Disclosures No Financial incentives No off label use
34 th Judicial District Substance Abuse Study Guide
34 th Judicial District Substance Abuse Study Guide What is Drug Addiction? 2 It is characterized by intense and, at times, uncontrollable drug craving, along with compulsive drug seeking and use that
And, despite the numbers, for many people, the Facts About Drugs are not clear.
According to the National Survey on Drug Use and Health (NSDUH), an estimated 20 million Americans aged 12 or older used an illegal drug in the past 30 days. This estimate represents 8% percent of the
Theonest Ndyetabura KILIMANJARO CHRISTIAN MEDICAL CENTRE / KILIMANJARO CLINICAL RESERCH
TREATMENT FAILURE AND PATTERNS OF GENOTYPIC DRUG RESISTANCE MUTATIONS AMONG HAART EXPERIENCED HIV-1 PATIENTS AT KCMC Theonest Ndyetabura KILIMANJARO CHRISTIAN MEDICAL CENTRE / KILIMANJARO CLINICAL RESERCH
It s In The Cards: Pharmaceutical Co-pay and Patient Assistance Programs. Jeff Berry Editor, Positively Aware
It s In The Cards: Pharmaceutical Co-pay and Patient Assistance Programs Jeff Berry Editor, Positively Aware PAPs, Co-Pays, and ADAPs, Oh My! Patient Assistance Programs (PAPs) provide free or low-cost
CHARLES & SUE S SCHOOL OF HAIR DESIGN DRUG AND ALCOHOL POLICY DRUG AND ALCOHOL POLICY; SUBSTANCE ABUSE RESOURCES:
CHARLES & SUE S SCHOOL OF HAIR DESIGN DRUG AND ALCOHOL POLICY DRUG AND ALCOHOL POLICY; SUBSTANCE ABUSE RESOURCES: At Charles & Sue s School of Hair Design, the illicit use of drugs and/or alcohol by staff
AIDS ACCESS FOUNDATION/ MSF AIDS can be Treated: A handbook of Antiretroviral medicines. AIDS Can Be Treated. A Hand Book of Antiretroviral medicines
AIDS Can Be Treated A Hand Book of Antiretroviral medicines The translation of this booklet is due to support from the Working Together Regional Training Project of the AIDS Access Foundation, Bangkok
NON-OCCUPATIONAL POST EXPOSURE PROPHYLAXIS FOR SEXUAL ASSAULT SURVIVORS. Carl LeBuhn, MD
NON-OCCUPATIONAL POST EXPOSURE PROPHYLAXIS FOR SEXUAL ASSAULT SURVIVORS Carl LeBuhn, MD Post-Exposure Prophylaxis (PEP) The use of therapeutic agents to prevent infection following exposure to a pathogen
Benzodiazepines. And Sleeping Pills. Psychological Medicine
Benzodiazepines And Sleeping Pills Psychological Medicine Introduction Benzodiazepines are a type of medication prescribed by doctors for its therapeutic actions in various conditions such as stress and
Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Postexposure Prophylaxis
Please note: These guidelines have been updated. To view the update, please click here. Morbidity and Mortality Weekly Report Recommendations and Reports September 30, 2005 / Vol. 54 / No. RR-9 Updated
FARMACI, INNOVAZIONE e INFEZIONE DA HIV / AIDS
FARMACI, INNOVAZIONE e INFEZIONE DA HIV / AIDS Stefano Vella Dipartimento del Farmaco Istituto Superiore di Sanità - Roma Stages of HIV-1 Life Cycle Targeted by Anti-HIV Drugs In: Gulick RM, Topics HIV
LIQUID DRUG FORMULATIONS. Formulation Status Cost Comments. facilitated access
LIQUID DRUG FORMULATIONS Drug ANTIRETROVIRALS FIXED DOSE COMBINATION PRODUCTS Atripla (efavirenz/ emtricitabine/ tenofovir) No Atripla FDC tablet crushed, dissolved in 5 ml of water and diluted to 20 ml
Ultram (tramadol), Ultram ER (tramadol extended-release tablets); Conzip (tramadol extended-release capsules), Ultracet (tramadol / acetaminophen)
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.02.35 Subject: Tramadol Acetaminophen Page: 1 of 8 Last Review Date: September 18, 2015 Tramadol Acetaminophen
Update and Review of Medication Assisted Treatments
Update and Review of Medication Assisted Treatments for Opiate and Alcohol Use Disorders Richard N. Whitney, MD Medical Director Addiction Services Shepherd Hill Newark, Ohio Medication Assisted Treatment
Generic antiretrovirals in Europe: a blessing or a curse?
Generic antiretrovirals in Europe: a blessing or a curse? Ricardo Jorge Camacho 1 Molecular Biology Laboratory, Centro Hospitalar de Lisboa Ocidental 2 Instituto de Higiene e Medicina Tropical, Universidade
Herta Crauwels, et al.: Rilpivirine Drug-Drug Interactions
AIDS Rev. 2013;15:87 101 Herta Crauwels, et al.: Rilpivirine Drug-Drug Interactions Clinical Perspective on Drug Drug Interactions with the Non-nucleoside Reverse Transcriptase Inhibitor Rilpivirine Herta
Drug Interactions in HIV/HCV coinfection
HIV/HCV Drug Interactions Case Based Discussion John J. Faragon, PharmD, BCPS, AAHIVP Regional Pharmacy Director, NY/NJ AETC HIV Pharmacist, Albany Medical Center 1 Drug Interactions in HIV/HCV coinfection
Drug and Alcohol Abuse Training revised: October 2015
Drug and Alcohol Abuse Training revised: October 2015 FMCSA is considering going to a seven panel and possibly ten panel. Hair testing may also be acceptable. What is a Drug? A substance which
Pharmacy and supermarket drugs
Pharmacy and supermarket Benzodiazepines Stimulants Tobacco drugs 185 8 Pharmacy and supermarket drugs Overview Over-the-counter medicines Prescribed medicines that are misused or sold on the streets Alcohol-based
Methamphetamine. Like heroin, meth is a drug that is illegal in some areas of the world. Meth is a highly addictive drug.
Methamphetamine Introduction Methamphetamine is a very addictive stimulant drug. People who use it can form a strong addiction. Addiction is when a drug user can t stop taking a drug, even when he or she
Access and coverage of antiretroviral drugs through Canada s provincial and territorial drug programs
Access and coverage of antiretroviral drugs through Canada s provincial and territorial drug programs Provinces/Territory Drug Dose Form Alberta British Columbia Manitoba New Brunswick Newfoundland & Labrador
Substance Use Learning Event Nov 3, 2015 Bill Bullock MD, CCFP
Substance Use Learning Event Nov 3, 2015 Bill Bullock MD, CCFP Medical assessment of patient with Alcohol Use Disorder Identification patients suitable for home detox Process for referral to inpatient
DRUG AND ALCOHOL ABUSE PREVENTION POLICY
DRUG AND ALCOHOL ABUSE PREVENTION POLICY The University of Houston (the University ) prohibits the unlawful possession, use, manufacture, or distribution of illicit drugs in the workplace, on the campus,
Education grant to fund the project
Education grant to fund the project Author Rachel Therrien, Pharmacist at CHUM s (Centre hospitalier de l Université de Montréal) UHRESS (Unité hospitalière de recherche, d enseignement et de soins sur
MODULE #8: Substance Abuse Awareness and Prevention
MODULE #8: Substance Abuse Awareness and Prevention Objectives Participants will learn how alcohol and other depressant drugs slow down the thinking process. Participants will be able to measure the frequency
Chapter 36. Media Directory. Characteristics of Viruses. Primitive Structure of Viruses. Therapy for Viral Infections. Drugs for Viral Infections
Chapter 36 Media Directory Drugs for Viral Infections Slide 23 Slide 27 Slide 29 Zidovudine Animation Saquinavir Mesylate Animation Acyclovir Animation Upper Saddle River, New Jersey 07458 All rights reserved.
Managing potential drug-drug interactions to achieve success in HCV triple therapy. David Back University of Liverpool
Managing potential drug-drug interactions to achieve success in HCV triple therapy David Back University of Liverpool Understanding the metabolic pathways of DAAs Drug CYP 3A4 P-gp Telaprevir Boceprevir
DRUG AND ALCOHOL ABUSE PREVENTION POLICY
1 DRUG AND ALCOHOL ABUSE PREVENTION POLICY The University of Houston (the University ) prohibits the unlawful possession, use, manufacture, or distribution of illicit drugs in the workplace, on the campus,
Drug and Alcohol Abuse Prevention Program
Drug and Alcohol Abuse Prevention Program of Bethany Global University Bethany Global University (BGU) has adopted the following policy in compliance with the Drug Free Workplace Act of 1988 and the subsequent
SMU Drug Free Schools and Campuses Information for New Employees
SMU Drug Free Schools and Campuses Information for New Employees UNIVERSITY POLICIES: Student Code of Conduct Human Resources - Controlled Substance Abuse in the Workplace Employee Assistance RISKS ASSOCIATED
Cocaine. Like heroin, cocaine is a drug that is illegal in some areas of the world. Cocaine is a commonly abused drug.
Cocaine Introduction Cocaine is a powerful drug that stimulates the brain. People who use it can form a strong addiction. Addiction is when a drug user can t stop taking a drug, even when he or she wants
Living With HIV A guide to your long-term health
FOCUS Living With HIV A guide to your long-term health Supplement to POZ magazine Living With HIV By Liz Highleyman The fact that HIV-positive people can live long, healthy lives comes as a surprise to
The treatment of HIV is currently focused on drug
Vol 1 October 2009 Clinical Pharmacist 393 Since the advent of combination antiretroviral therapy in the mid-1990s HIV-infected individuals are now living longer with improved quality of life. Medication
Drug and Alcohol Abuse Prevention Program
Drug and Alcohol Abuse Prevention Program The Office of Human Resources FY 2014/2015 Austin Community College Drug and Alcohol Abuse Prevention Program The Austin Community College District (ACC) is dedicated
PEP Step 2: Report and Document
RISK The risk of exposure to blood and bloodborne pathogens is slightly greater for health care personnel (HCP) than for people who do not work around blood. An exposure to infected blood, tissue, or other
DRUGS OF ABUSE CLASSIFICATION AND EFFECTS
Drug and Drug use DRUGS OF ABUSE CLASSIFICATION AND EFFECTS A pharmaceutical preparation or a naturally occurring substance used primarily to bring about a change in the existing process or state (physiological,
Interactions Between Antiretrovirals and Antiplatelet Agents and Novel Oral Anticoagulants
Dosing Metabolism Clopidogrel (Plavix ) 300mg 600mg loading dose 75 mg daily maintenance dose Prodrug activated by CYP2C19 (major), CYP2B6 & metabolism. CYP2B6. 1 Prasugrel (Effient ) 60mg loading dose
KAP Keys. For Physicians. Based on TIP 40 Clinical Guidelines for the Use of Buprenorphine in the Treatment. of Opioid Addiction
Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction Knowledge Application Program KAP Keys For Physicians Based on TIP 40 Clinical Guidelines for the Use of Buprenorphine
Alcohol Withdrawal. Introduction. Blood Alcohol Concentration. DSM-IV Criteria/Alcohol Abuse. Pharmacologic Effects of Alcohol
Pharmacologic Effects of Alcohol Alcohol Withdrawal Kristi Theobald, Pharm.D., BCPS Therapeutics III Fall 2003 Inhibits glutamate receptor function (NMDA receptor) Inhibits excitatory neurotransmission
CHAPTER 2B HIV DRUG-DRUG INTERACTIONS I. INTRODUCTION GENERAL RECOMMENDATIONS:
CHAPTER 2B HIV DRUG-DRUG INTERACTIONS I. INTRODUCTION II. GENERAL RECOMMENDATIONS: The practitioner should conduct a thorough medication history at each visit that includes prescription medications, over-the-counter
THE BASICS. Community Based Medically Assisted Alcohol Withdrawal. World Health Organisation 2011. The Issues 5/18/2011. RCGP Conference May 2011
RCGP Conference May 2011 Community Based Medically Assisted Alcohol Withdrawal THE BASICS An option for consideration World Health Organisation 2011 Alcohol is the world s third largest risk factor for
DRUG & ALCOHOL ABUSE PREVENTION PROGRAM
DRUG & ALCOHOL ABUSE PREVENTION PROGRAM Introduction South Hills has an obligation to do whatever we can to make sure our students are aware of the dangers of drugs and to not use drugs. We not only have
Policy. Drug- Free School and Communities Act
Policy In keeping with Mid- America Christian University s (MACU) commitment to provide a safe and healthy academic and work environment, the University maintains a drug and alcohol free campus. The University
Substance Abuse and HIV Infection
Perspective Substance Abuse and HIV Infection Substance abuse facilitates the spread of HIV infection and complicates its management. Successful treatment of HIV disease and other comorbidities in substance
OVERVIEW WHAT IS POLyDRUG USE? Different examples of polydrug use
Petrol, paint and other Polydrug inhalants use 237 11 Polydrug use Overview What is polydrug use? Reasons for polydrug use What are the harms of polydrug use? How to assess a person who uses several drugs
PRESCRIPTION DRUG ABUSE prevention
PRESCRIPTION DRUG ABUSE prevention Understanding Drug Addiction Many people do not understand how someone could abuse drugs even when their life seems to be falling apart. It is often assumed that those
BENZODIAZEPINES. Benzodiazepines may be habit-forming (causing mental or physical dependence), especially when taken for a long time or in high doses.
Some commonly used brand names are: BENZODIAZEPINES Ativan (lorazepam), Dalmane (flurazepam), Diastat or Valium (diazepam),, Doral (quazepam), Halcion (triazolam), Klonopin (clonazepam), Librium (chlordiazepoxide),
1. According to recent US national estimates, which of the following substances is associated
1 Chapter 36. Substance-Related, Self-Assessment Questions 1. According to recent US national estimates, which of the following substances is associated with the highest incidence of new drug initiates
Regulatory Approach in Germany and in the EU to Fixed Dose Combination Medicinal Products Using HIV/AIDS Treatment as an Example
Regulatory Approach in Germany and in the EU to Fixed Dose Combination Medicinal Products Using HIV/AIDS Treatment as an Example Prof. Dr. rer. nat. habil. Harald G. Schweim President Federal Institute
New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery
New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery USING THE 48 HOUR OBSERVATION BED USING THE 48 HOUR OBSERVATION BED Detoxification
Patient Information VYTORIN (VI-tor-in) (ezetimibe and simvastatin) Tablets
Patient Information VYTORIN (VI-tor-in) (ezetimibe and simvastatin) Tablets Read this Patient Information carefully before you start taking VYTORIN and each time you get a refill. There may be new information.
Like cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive.
Heroin Introduction Heroin is a powerful drug that affects the brain. People who use it can form a strong addiction. Addiction is when a drug user can t stop taking a drug, even when he or she wants to.
Antiretroviral therapy for HIV infection in infants and children: Towards universal access
Antiretroviral therapy for HIV infection in infants and children: Towards universal access Executive summary of recommendations Preliminary version for program planning 2010 Executive summary Tremendous
CIALIS (See-AL-iss) (tadalafil) tablets
1 Patient Information CIALIS (See-AL-iss) (tadalafil) tablets Read this important information before you start taking CIALIS and each time you get a refill. There may be new information. You may also find
Social and Economic costs of HIV and AIDS. Current issues. Sarah Ann Adomakoh. Costs, cost-effectiveness & Sustainability
Associates for International Development Social and Economic costs of HIV and AIDS Current issues Suite A East Wing ARS Medicae Building No. 14, 6 th Avenue, Belleville St Michael Barbados Tel (246) 429